TROP-MI-STAGE is a multicenter retrospective diagnostic study designed to evaluate the role of high-sensitivity cardiac troponin I (hs-cTnI) in the diagnosis and clinical stage classification of acute myocardial infarction as defined by the stages of myocardial injury in CCS-AMI classification. The study retrospectively analyzes biomarker data from patients diagnosed with AMI across multiple institutions, focusing on whether hs-cTnI levels-measured at specific time points-can reliably identify and stratify patients into AMI clinical stages (Stage 1 to Stage 4). It aims to correlate hs-cTnI kinetics and peak levels with clinical stage, presentation patterns, and outcomes. This trial seeks to offer a biomarker-based alternative to imaging-heavy staging, potentially streamlining early diagnosis and therapeutic triage for AMI patients in varied clinical settings.
Study Type
OBSERVATIONAL
Enrollment
312
Medical Imaging Research Institute
Indianapolis, Indiana, United States
High-sensitivity Cardiac Troponin-I Thresholds
Levels of hs-cTn-I to differentiate AMI Stages I-IV (Classified by CMR)
Time frame: 48 hours
Time window for high-sensitivity cardiac troponin-I thresholds
Define time window for high-sensitivity cardiac troponin-I threshold for AMI Stages I-IV
Time frame: 48 hours
Adjusted Risk Ratio
Adjusted Risk Ratio to explore parameters to predict AMI Stages I-IV
Time frame: 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.